• Noveris Health Sciences Inc. held its annual general and special meeting on Sept. 4, 2026.
• Shareholders set the board size at three directors.
• Shareholders elected Jason Birmingham, Michael Callas, Peter Field to serve until the next annual meeting.
• HDCPA Professional Corporation was appointed auditor for the ensuing year; directors were authorized to set remuneration.
• Shareholders adopted an amended omnibus long-term incentive plan, also approved an articles amendment to change quorum requirements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Noveris Health Sciences Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609091705NEWSFILECNPR____20260909_313698_1) on September 09, 2026, and is solely responsible for the information contained therein.